Related Experiment Videos

Biomarkers in benign breast disease: risk factors for breast cancer

D C Allred, S G Hilsenbeck

Journal of the National Cancer Institute

|September 10, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Breast cancer research : BCR·2018

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.

Breast cancer research and treatment·2017

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis.

Cell death and differentiation·2013

Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives.

Public health genomics·2012

Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.

Oncogene·2011

See all related articles